Patent Medicine Dealers and Irrational Use of Medicines in Children: The Economic Cost and Implications for Reducing Childhood Mortality in Southeast Nigeria

This study assessed the economic costs of irrational medicine use by Patent Medicine Dealers (PMDs) for malaria, acute respiratory infection (ARI) and diarrhea diseases (DD) in Nigeria. Exit interviews were conducted with 395 respondents who sought care for their children from 15 PMDs in Abakpa district of Enugu state Nigeria. Of the total respondents, 80.0% received treatment for malaria while 12.0% and 8.0% received treatment for DD and ARI respectively. The average number of drugs dispensed per patient was 6.8, average percentage of patients given injections was 72.5%, average percentage of patients given one or more antibiotics was 59.7%, while the percentage of patients given non essential drugs was 45.9%. The additional costs to the standard treatment in Naira was 255, 350 and 175 for malaria, ARI and DD respectively. The losses attributable to irrational dispensing was 4,500 Naira. However, more than half of the drugs were on essential drug list, implying some cost savings for the consumers, but the high number of drugs (6.8) on average/patient is likely to increase the total cost of drugs cancelling out the cost savings to consumers arising from dispensing essential drugs.

[1]  K. Ukwaja,et al.  Home management of acute respiratory infections in a Nigerian district , 2015 .

[2]  W. Erhun,et al.  Drug Regulation and Control in Nigeria: the Challenge of Counterfeit Drugs , 2013 .

[3]  B. Ganguly,et al.  Prescribing pattern in a pediatric out-patient department in Gujarat , 2008 .

[4]  L. Jong‐van den Berg,et al.  Antibiotic drug use of children in the Netherlands from 1999 till 2005 , 2008, European Journal of Clinical Pharmacology.

[5]  C. Onoka,et al.  Rural-Urban Differences in Maternal Responses to Childhood Fever in South East Nigeria , 2008, PloS one.

[6]  F. Tayo,et al.  Cost implication of irrational prescribing of chloroquine in Lagos State general hospitals. , 2008, Journal of infection in developing countries.

[7]  A. Mills,et al.  Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved? , 2007, The American journal of tropical medicine and hygiene.

[8]  S. Ochola,et al.  Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions , 2007, Malaria Journal.

[9]  W. Qidwai,et al.  Private drug sellers' education in improving prescribing practices. , 2006, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[10]  B. Uzochukwu,et al.  An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community , 2006, Malaria Journal.

[11]  S. E. Nsimba,et al.  Assessing prescribing and patient care indicators for children under five years old with malaria and other disease conditions in public primary health care facilities. , 2006, The Southeast Asian journal of tropical medicine and public health.

[12]  M. Rohela,et al.  A retrospective prevalence study of malaria in an aborigine hospital in Gombak, Selangor, Malaysia. , 2006, The Southeast Asian journal of tropical medicine and public health.

[13]  Y. Peerapornpisal,et al.  Toxicological evaluation of Cladophora glomerata Kützing and Microspora floccosa Thuret in albino rats. , 2006, The Southeast Asian journal of tropical medicine and public health.

[14]  O. Onwujekwe,et al.  Inequity in the Bamako Initiative programme--implications for the treatment of malaria in south-east Nigeria. , 2004, The International journal of health planning and management.

[15]  O. Onwujekwe,et al.  Socio-economic differences and health seeking behaviour for the diagnosis and treatment of malaria: a case study of four local government areas operating the Bamako initiative programme in south-east Nigeria , 2004, International journal for equity in health.

[16]  Oladimeji Oladepo,et al.  Interactions between patent medicine vendors and customers in urban and rural Nigeria. , 2004, Health policy and planning.

[17]  O. Onwujekwe,et al.  Effect of the Bamako-Initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria. , 2002, Health policy and planning.

[18]  R. Northrup,et al.  Utilizing the potential of formal and informal private practitioners in child survival: situation analysis and summary of promising interventions. , 2002 .

[19]  B. Reeves,et al.  The effects of different kinds of user fee on prescribing costs in rural Nepal. , 2001, Health policy and planning.

[20]  C. O. Akinlade,et al.  Treatment of childhood fevers and other illnesses in three rural Nigerian communities. , 2001, Journal of tropical pediatrics.

[21]  O. Onwujekwe,et al.  Economic burden of malaria illness on households versus that of all other illness episodes: a study in five malaria holo-endemic Nigerian communities. , 2000, Health policy.

[22]  N. Biswas,et al.  Patterns of prescriptions and drug use in two tertiary hospitals in Delhi. , 2000, Indian journal of physiology and pharmacology.

[23]  R. C. Pandey,et al.  EVALUATION OF PRESCRIBING PATTERN OF DOCTORS FOR RATIONAL DRUG THERAPY , 1998 .

[24]  A Zwi,et al.  Improving the quality of private sector delivery of public health services: challenges and strategies. , 1998, Health policy and planning.

[25]  D. Sanders,et al.  Questioning the solution : the politics of primary health care and child survival with an in-depth critique of oral rehydration therapy , 1997 .

[26]  A. Massele,et al.  Knowledge and management of malaria in Dar es Salaam, Tanzania. , 1993, East African medical journal.

[27]  A. Ojuawo,et al.  Treatment of diarrhoea by proprietary-medicine vendors. , 1993, Nigerian journal of paediatrics.

[28]  W. Brieger,et al.  Primary care training for patent medicine vendors in rural Nigeria. , 1992, Social science & medicine.

[29]  S. Geest.  Marketplace conversations in Cameroon: How and why popular medical knowledge comes into being , 1991 .

[30]  A. Viana Alonso,et al.  Rational Use of Drugs , 1985, The Lancet.